AURA's Quality Score fell 1 point on Mon, Nov 2, to -4. Trading picked back up.
Follow AURA's trial news. Pro members can get an alert when Aura Biosciences files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 59% since it listed in Oct 2021 while the S&P 500 rose 76%.
| Holding it back | 63.5% more shares than a year ago |
| Latest filing | 10-Q, Aug 11 |
After its last 4 reports it closed -0.1% on average, higher 1 of 4 times.
The company says its cash lasts into 1H 2029 (8-K, Aug 11).
CFO Anthony S Gibney sold 12,824 shares on Jun 16. 8 more insider trades this year.
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
Poorfor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
AURA is #188 of 291 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 188 |
Expected to report Thu Nov 12, before the open (in 10 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“Research and development expenses increased to $30.7 million for the three months ended June 30, 2026 from $22.9 million for the three months ended June 30, 2025, primarily due to ongoing clinical and CRO costs associated with the progression of the CoMpass global Phase 3 trial of bel-sar in early choroidal melanoma and manufacturing and development costs for bel-sar.”
AURA's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
“The increase was primarily driven by increased stock-based compensation expense resulting from equity award modifications in connection with executive leadership transitions, as well as higher professional fees.”
From its results filing (SEC filing · Aug 11)
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 11, 2026 | -1.9% | +4.4% | -0.3% |
| May 11, 2026 | -3.8% | -3.2% | -8.8% |
| Mar 30, 2026 | +0.5% | -1.1% | +6.5% |
2 insiders sold $39.1M across 2 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: AURA is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
AURA scores -4 today, which Breakaway calls Poor. It is #188 of 291 in Biotech by Quality Score, with 2 of 14 chart checks firing. Down 59% since it listed in Oct 2021 while the S&P 500 rose 76%. Shares: 63.5% more than a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
AURA scores -4 today, which Breakaway calls Poor (below zero). That is #188 of 291 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind AURA's -4.
2 insiders sold $39.1M across 2 filings in the last 6 months. No open-market buys on record. The newest is Anthony S. Gibney, Insider, who sold $82K on Jun 16. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.